"A study from the Tisch MS Research Center of New York suggests that microglia could be a potential target for mesenchymal stem cell-derived neural progenitor cell (MSC-NP) therapy."
Click here to read the full article.
521 West 57th Street
New York, NY 10019
Support Tisch MS and our innovative research leading to treatments that improve the lives of patients.
Safe & Secure
This is the website of the Tisch MS Research Center of New York, a non-profit, 501(c)(3), independent, multiple sclerosis research center, and not a medical practice. CLICK HERE to be directed to our clinical affiliate, the International Multiple Sclerosis Management Practice.
521 West 57 St., 4th Flr, NY, NY 10019 | ©2017 Tisch MS All rights reserved.